MX2022009581A - Vectores virales adeno-asociados recombinantes en plantas. - Google Patents
Vectores virales adeno-asociados recombinantes en plantas.Info
- Publication number
- MX2022009581A MX2022009581A MX2022009581A MX2022009581A MX2022009581A MX 2022009581 A MX2022009581 A MX 2022009581A MX 2022009581 A MX2022009581 A MX 2022009581A MX 2022009581 A MX2022009581 A MX 2022009581A MX 2022009581 A MX2022009581 A MX 2022009581A
- Authority
- MX
- Mexico
- Prior art keywords
- plants
- nucleic acid
- aav
- viral vectors
- associated viral
- Prior art date
Links
- 239000013603 viral vector Substances 0.000 title 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 108020004705 Codon Proteins 0.000 abstract 1
- 241000702421 Dependoparvovirus Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente descripción se refiere a secuencias de ácidos nucleicos que codifican para componentes de virus adenoasociados (AAV), tal como aquellos que han sido optimizados por codones para su expresión en plantas, y las proteínas que se expresan a partir de estas secuencias de ácidos nucleicos. También se describen métodos para producir partículas de AAV funcionales usando estas secuencias de ácido nucleico en plantas. La producción de AAV en plantas como se describe en la presente ofrece muchas ventajas con respecto a los procesos convencionales, tal como eficiencia, costo, rendimiento, escalabilidad y seguridad.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062971750P | 2020-02-07 | 2020-02-07 | |
PCT/US2021/016393 WO2021158648A1 (en) | 2020-02-07 | 2021-02-03 | Recombinant adeno-associated viral vectors in plants |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022009581A true MX2022009581A (es) | 2022-10-18 |
Family
ID=77199437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022009581A MX2022009581A (es) | 2020-02-07 | 2021-02-03 | Vectores virales adeno-asociados recombinantes en plantas. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20230087751A1 (es) |
EP (1) | EP4100056A4 (es) |
JP (1) | JP2023512831A (es) |
KR (1) | KR20220139903A (es) |
CN (1) | CN115361970A (es) |
AU (1) | AU2021215860A1 (es) |
CA (1) | CA3170169A1 (es) |
MX (1) | MX2022009581A (es) |
WO (1) | WO2021158648A1 (es) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6204059B1 (en) * | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
US6383794B1 (en) * | 1998-08-24 | 2002-05-07 | Uab Research Foundation | Methods of producing high titer recombinant adeno-associated virus |
US20030225260A1 (en) * | 2002-04-30 | 2003-12-04 | Snyder Richard O. | Production of recombinant AAV virions |
EP1979485A2 (en) * | 2006-01-31 | 2008-10-15 | The Board Of Trustees Of The Leland Stanford Junior University | Self-complementary parvoviral vectors, and methods for making and using the same |
CN103849629B (zh) * | 2006-06-21 | 2017-06-09 | 尤尼克尔Ip股份有限公司 | 具有经修饰的用于在昆虫细胞中产生aav的aav‑rep78翻译起始密码子的载体 |
US9115373B2 (en) * | 2007-09-19 | 2015-08-25 | Uniqure Ip B.V. | Use of AAV replication machinery for improved protein production |
EP2403867B1 (en) * | 2009-03-04 | 2019-05-22 | Deutsches Krebsforschungszentrum | Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3 |
EP2440035B1 (en) * | 2009-06-11 | 2017-03-08 | Syngenta Participations AG | A method for the transient expression of nucleic acids in plants |
US9994859B2 (en) * | 2013-07-25 | 2018-06-12 | University Of Cape Town | Plant produced human papillomavirus pseudovirion |
US11053509B2 (en) * | 2016-04-19 | 2021-07-06 | Csir | Plant-produced chimaeric Orbivirus VLPs |
EP4077684A1 (en) * | 2019-12-18 | 2022-10-26 | Genethon | Production of recombinant viral vectors from plant hairy roots |
-
2021
- 2021-02-03 WO PCT/US2021/016393 patent/WO2021158648A1/en unknown
- 2021-02-03 JP JP2022548130A patent/JP2023512831A/ja active Pending
- 2021-02-03 MX MX2022009581A patent/MX2022009581A/es unknown
- 2021-02-03 US US17/795,822 patent/US20230087751A1/en active Pending
- 2021-02-03 EP EP21751090.8A patent/EP4100056A4/en active Pending
- 2021-02-03 KR KR1020227029056A patent/KR20220139903A/ko active Search and Examination
- 2021-02-03 CN CN202180026407.XA patent/CN115361970A/zh active Pending
- 2021-02-03 AU AU2021215860A patent/AU2021215860A1/en active Pending
- 2021-02-03 CA CA3170169A patent/CA3170169A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20220139903A (ko) | 2022-10-17 |
EP4100056A1 (en) | 2022-12-14 |
WO2021158648A1 (en) | 2021-08-12 |
CN115361970A (zh) | 2022-11-18 |
CA3170169A1 (en) | 2021-08-12 |
JP2023512831A (ja) | 2023-03-29 |
EP4100056A4 (en) | 2024-03-06 |
AU2021215860A1 (en) | 2022-09-22 |
US20230087751A1 (en) | 2023-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019010275A (es) | Novedoso vector del subtipo f del virus adenoasociado (aav) y usos de este. | |
AU2017261249A1 (en) | Adeno-associated virus polynucleotides, polypeptides and virions | |
WO2012145509A3 (en) | Adeno-associated-virus rep sequences, vectors, and viruses | |
EA201101553A1 (ru) | Полипептид, деградирующий углеводы, и его применения | |
GB201201178D0 (en) | Novel enzymes | |
WO2013151670A3 (en) | Modified polynucleotides for the production of nuclear proteins | |
JP2013511481A5 (es) | ||
RU2014135703A (ru) | Оптимизированные с помощью компьютера антигены с широким спектром реактивности для вирусов гриппа h3n2, h2n2 и b | |
MX340485B (es) | Vectores de expresion para una secrecion de proteina mejorada. | |
MX2022010388A (es) | Polipéptidos de la cápside y vectores de virus adenoasociado. | |
PH12020552252A1 (en) | Influenza virus hemagglutinin mutants | |
CN114990089B (zh) | 微型内含肽Ssa DnaH及其在表达分离六肽-8中的应用 | |
RU2014144881A (ru) | Способ экспрессии полипептидов с применением модифицированных нуклеиновых кислот | |
MX2022009581A (es) | Vectores virales adeno-asociados recombinantes en plantas. | |
MX2022013504A (es) | Composiciones útiles en el tratamiento del trastorno de deficiencia de cdkl5 (cdd). | |
JP2019503171A5 (es) | ||
DE60326444D1 (de) | Verbesserte chimäre glykoproteine und pseudotypisierte lentivirale vektoren | |
JP2013514811A5 (es) | ||
KR102121817B1 (ko) | Crispr 편집 기술을 이용한 재조합 항원을 발현시키는 벡터 및 이를 동시에 다중 삽입시키는 방법 | |
KR101434739B1 (ko) | 인간 PDIb´a´태그를 이용한 생물학적 활성을 가진 인간 LIF 재조합 단백질의 대장균 내 발현 및 정제방법 | |
JP2019530637A5 (es) | ||
WO2023225545A3 (en) | Liver de-targeted recombinant aav capsid proteins | |
MX2023003994A (es) | Construcciones de acido nucleico, vectores virales y particulas virales. | |
MX2022002602A (es) | Inmunogenos recombinantes para la produccion de anticuerpos contra el veneno de alacranes del genero tityus y centruroides. | |
WO2023115027A8 (en) | Detergent for viral inactivation |